Artal Group’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $8.23M | Sell |
|
|||||
|
2024
Q1 | $5.94M | Hold |
|
|||||
|
2023
Q4 | $6.3M | Hold |
|
|||||
|
2023
Q3 | $9.69M | Hold |
|
|||||
|
2023
Q2 | $10.2M | Buy |
|
|||||
|
2023
Q1 | $6.79M | Hold |
|
|||||
|
2022
Q4 | $5.52M | Hold |
|
|||||
|
2022
Q3 | $8.01M | Hold |
|
|||||
|
2022
Q2 | $6.4M | Buy |
|
|||||
|
2022
Q1 | $4.92M | Hold |
|
|||||
|
2021
Q4 | $13M | Hold |
|
|||||
|
2021
Q3 | $16.6M | Hold |
|
|||||
|
2021
Q2 | $16.7M | Sell |
|
|||||
|
2021
Q1 | $20.4M | Hold |
|
|||||
|
2020
Q4 | $13.6M | Hold |
|
|||||
|
2020
Q3 | $11.2M | Buy |
|
|||||
|
2020
Q2 | $8.24M | Sell |
|
|||||
|
2020
Q1 | $8.23M | Hold |
|
|||||
|
2019
Q4 | $8.12M | Buy |
|
|||||
|
2019
Q3 | $3.67M | Hold |
|
|||||
|
2019
Q2 | $3.76M | Hold |
|
|||||
|
2019
Q1 | $4.98M | Buy |
|
|||||
|
2018
Q4 | $1.6M | Buy |
|
|||||
|
2018
Q3 | $8.73M | Buy |
|
|||||
|
2018
Q2 | $6.63M | Buy |
|
|||||
|
2018
Q1 | $1.27M | Buy |
|